Save time and get answers to complex questions with AI chat
Dabrafenib mesylate when the patent is expiring in india?When does guselkumab patent expire?Patent expiration date of guselkumab?When is the expected fda decision date for apotex's ruxolitinib resubmission?Defense strategy against generic in niche market?
See the DrugPatentWatch profile for Semglee
Short answer: Both Semglee and Basaglar are long-acting insulin glargine biosimilars to Lantus and are used to provide steady basal insulin in type 1 or type 2 diabetes. They’re very similar, but there are regulatory and practical differences. Key points - What they are - Semglee: insulin glargine (biosimilar to Lantus), made by Viatris/Biocon. - Basaglar: insulin glargine (biosimilar to Lantus), made by Eli Lilly. - Regulator status (US) - Semglee has been designated interchangeable with Lantus in the US, allowing pharmacy-level substitution in many cases (depending on state rules and prescriber involvement). - Basaglar is a biosimilar but is not designated interchangeable in the US. - Outside the US, interchangeability rules differ by country. - How they’re used - Both are once-daily (or per-physician) basal insulins given by injection. - Both come in 100 units/mL formulations and are delivered with insulin pens or vials (device options vary by market). - Cost and coverage - Prices and insurance coverage can vary by plan and country. In many places, biosimilars offer savings vs. the brand-name Lantus, but exact costs depend on your formulary. - Practical considerations - If your payer allows substitution (and you’re in a region where Semglee is interchangeable), you might see a switch from Lantus or Basaglar to Semglee at the pharmacy. - If you’re switching between Semglee and Basaglar, monitor blood glucose and follow your clinician’s guidance. - Storage basics - Unopened vials/pens: refrigerate (2-8°C) until use. - In-use: follow label instructions (storage at room temperature and discard after a specified window, typically weeks to a month depending on the product and local guidelines). - Do not mix with other insulins in the same syringe unless explicitly allowed by the product instructions. If you want, tell me your country (US vs elsewhere), your insurer or formulary info, and whether you’re considering switching from one to the other. I can tailor cost, substitution rules, and a quick dosing/handling guide for your situation.
Other Questions About Semglee :